Prosecution Insights
Last updated: April 19, 2026
Application No. 18/279,410

HERBICIDAL MIXTURES AND COMPOSITIONS AND METHODS OF USE

Non-Final OA §102§112
Filed
Aug 30, 2023
Examiner
AZPURU, CARLOS A
Art Unit
1617
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Sbm Développement SAS
OA Round
1 (Non-Final)
84%
Grant Probability
Favorable
1-2
OA Rounds
2y 9m
To Grant
94%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allow Rate
1067 granted / 1276 resolved
+23.6% vs TC avg
Moderate +10% lift
Without
With
+10.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 9m
Avg Prosecution
23 currently pending
Career history
1299
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
23.0%
-17.0% vs TC avg
§102
18.4%
-21.6% vs TC avg
§112
29.8%
-10.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1276 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement An information disclosure statement was filed on 08/30/2023. Election/Restrictions Applicant’s election without traverse of Group I, claims 1-6, 12, 14, 17-22 in the reply filed on 01/21/2026 is acknowledged. Claims 23, 24, and 26-29 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 01/21/2026. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-6, 12, 14, and 17-22 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 sets out “an acid and/or salt and/or an ester of an acid”. What is an acid of an acid? Clarification is requested. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-5 is/are rejected under 35 U.S.C. 102(a)(2) as being anticipated by US 2017/0303537 (OMS). Regarding claim 1, OMS discloses an herbal mixture [0009] comprising an acid and/or salt and/or ester of an acid. The composition may include a monocarboxylic fatty acid, an essential oil . The acid is a fatty acid and/or an organic acid [0009]. An example of suitable linear monocarboxylic fatty acids is caprylic acid, pelargonic acid, capric acid [0017]. With regard to claim 2, the organic acid has a formula of C2H2nO2. These include pelargonic, caprylic, capric [0017]. The organic acids of claim 3, are set out in [0017]. Regarding claim 4, the fatty acid may have a formula of CH3(CH2)nCOOH linear monocarboxylic fatty acids which are listed in [0017]. With regard claim 5, [0017} sets out C8 organic acids such as caprylic , a C9 organic acid such as nonanoic acid, and a C10 organic acid such as capric acid. The claims are anticipated by OMS. Conclusion No claims are allowed. US 20080153870 is cited as a document of interest in its disclosure of an herbicidal agent mixed with a carrier comprising mono alkyl ester of long chain fatty acids. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to CARLOS A AZPURU whose telephone number is (571)272-0588. The examiner can normally be reached 9 am- 3 pm, 4 pm-8pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sue X Liu can be reached at 571-272-5539. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CARLOS A AZPURU/ Primary Examiner, Art Unit 1617 caz
Read full office action

Prosecution Timeline

Aug 30, 2023
Application Filed
Feb 25, 2026
Non-Final Rejection — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12589166
COMPOSITIONS AND METHODS FOR TREATING WOUNDS
2y 5m to grant Granted Mar 31, 2026
Patent 12582602
Tableted Cannabinoid Chewing Gum With Tableted Modules
2y 5m to grant Granted Mar 24, 2026
Patent 12569571
SALT RESPONSIVE NANOGELS AND NANOPARTICLES
2y 5m to grant Granted Mar 10, 2026
Patent 12569441
MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES
2y 5m to grant Granted Mar 10, 2026
Patent 12569457
COATED BETA HYDROXYBUTYRIC ACID CRYSTAL AND METHODS FOR PRODUCING THE SAME
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
84%
Grant Probability
94%
With Interview (+10.3%)
2y 9m
Median Time to Grant
Low
PTA Risk
Based on 1276 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month